GROUNDBREAKING CP STUDY RECEIVES FDA APPROVAL;
AWAITS FUNDING
Kids Will be Treated With Their Own Bone Marrow. No Cord Blood Required. This is why we started Let's Cure CP . A leading researcher at University of Texas Medical School at Houston has received approval from the FDA to start a groundbreaking study to treat CP kids with autologous (their own) stem cells.
Let’s Cure CP first approached Dr. Charles S. Cox, Jr., about doing this study almost two years ago, and we are overjoyed to see this dream come to fruition. This is the FIRST study of its kind in the United States that will treat CP kids with their own bone marrow. Until now, if you did not bank a child’s cord blood, there were no other options for this promising type of treatment in the U.S. That is about to change due to a powerful partnership between Let’s Cure CP and Dr. Cox.
The study will have two arms (groups). One arm is the bone marrow group and the second is the cord blood group. Dr. Cox and his team will compare the two types of stem cell lines and their efficacy.
Dr. Cox, who is the Children’s Fund, Inc. Distinguished Professor of Pediatric Surgery and directs the Pediatric Surgical Translational Laboratories and Pediatric Program in Regenerative Medicine at UT-Houston, will measure results in two ways:
1.Study baseline MRIs of the children and compare with post-treatment MRIs for any changes.
2.Compare baseline motor function and post-treatment motor function of the children.
The study will follow 30 children over a two-year period; 15 kids in each "arm." This will be a randomized, blind, crossover study, meaning that the patient and the parents will not know if they received the real infusion or placebo infusion at the start of the trial. EVERYONE will get treated in this trial; the children that received placebo at the start of the trial will receive treatment at the one-year follow-up visit. The children will be evaluated at baseline (start of the study); 6 months; 1 year after infusion; and 2 years after infusion.
Dr. Cox is ready to begin this astounding research, except he lacks one critical component: funding. That's why we NEED YOUR HELP more than ever! The study will not begin until more money is raised to fund it. To date, $300,000 has been raised; the study requires approximately $1.3 million dollars.
We at Let’s Cure CP are committed to making this trial happen! We are aggressively seeking corporate sponsors and reaching out to other foundations for help. Still, most research organizations get their donations from families and people affected by the disease and condition. That is why we are pleading to YOU, the CP community, to fight for the research and the treatments that we deserve. CP research has been underfunded and under-exposed, and it's time to change that.
AWAITS FUNDING
Kids Will be Treated With Their Own Bone Marrow. No Cord Blood Required. This is why we started Let's Cure CP . A leading researcher at University of Texas Medical School at Houston has received approval from the FDA to start a groundbreaking study to treat CP kids with autologous (their own) stem cells.
Let’s Cure CP first approached Dr. Charles S. Cox, Jr., about doing this study almost two years ago, and we are overjoyed to see this dream come to fruition. This is the FIRST study of its kind in the United States that will treat CP kids with their own bone marrow. Until now, if you did not bank a child’s cord blood, there were no other options for this promising type of treatment in the U.S. That is about to change due to a powerful partnership between Let’s Cure CP and Dr. Cox.
The study will have two arms (groups). One arm is the bone marrow group and the second is the cord blood group. Dr. Cox and his team will compare the two types of stem cell lines and their efficacy.
Dr. Cox, who is the Children’s Fund, Inc. Distinguished Professor of Pediatric Surgery and directs the Pediatric Surgical Translational Laboratories and Pediatric Program in Regenerative Medicine at UT-Houston, will measure results in two ways:
1.Study baseline MRIs of the children and compare with post-treatment MRIs for any changes.
2.Compare baseline motor function and post-treatment motor function of the children.
The study will follow 30 children over a two-year period; 15 kids in each "arm." This will be a randomized, blind, crossover study, meaning that the patient and the parents will not know if they received the real infusion or placebo infusion at the start of the trial. EVERYONE will get treated in this trial; the children that received placebo at the start of the trial will receive treatment at the one-year follow-up visit. The children will be evaluated at baseline (start of the study); 6 months; 1 year after infusion; and 2 years after infusion.
Dr. Cox is ready to begin this astounding research, except he lacks one critical component: funding. That's why we NEED YOUR HELP more than ever! The study will not begin until more money is raised to fund it. To date, $300,000 has been raised; the study requires approximately $1.3 million dollars.
We at Let’s Cure CP are committed to making this trial happen! We are aggressively seeking corporate sponsors and reaching out to other foundations for help. Still, most research organizations get their donations from families and people affected by the disease and condition. That is why we are pleading to YOU, the CP community, to fight for the research and the treatments that we deserve. CP research has been underfunded and under-exposed, and it's time to change that.